Previous 10 |
home / stock / oriny / oriny news
2023-07-31 16:54:37 ET Marinus Pharmaceuticals ( NASDAQ: MRNS ) and partner Orion Oyj ( OTCPK:ORINY ) said that the European Commission has granted market approval for Marinus's drug Ztalmy as an adjunctive treatment for epileptic seizures in children with CDKL5 deficiency disor...
Orion Oyj (ORINF) Q2 2022 Results Conference Call July 15, 2022 6:30 AM ET Company Participants Tuukka Hirvonen - Head, IR Timo Lappalainen - CEO Jari Karlson - CFO Conference Call Participants Jo Walton - Credit Suisse Sami Sarkamies - Danske Ban...
The following slide deck was published by Orion Oyj in conjunction with their 2022 Q2 earnings call. For further details see: Orion Oyj 2022 Q2 - Results - Earnings Call Presentation
Orion Corporation (OTCPK:ORINY) to acquire Belgian based Inovet BV and its wholly owned subsidiary V.M.D. NV and all companies belonging to V.M.D. NV’s group of companies for ~EUR 130M debt free. VMD is a veterinary pharmaceuticals company specialised in medicines and health ...
Orion Oyj (ORINF) Q1 2022 Results Conference Call April 28, 2022 06:30 AM ET Company Participants Tuukka Hirvonen - Head, IR Timo Lappalainen - CEO Jari Karlson - CFO Conference Call Participants Harry Sephton - Credit Suisse Sami Sarkamies - Danske Bank Presentation Tuukka Hirvonen Good afte...
My portfolio crossed the mark where I could lock in capital gains, switch decidedly to income stocks and retire today. That is, if these income stocks yield at least some 4.5%. Yield is easy to find, but can it be relied on? For further details see: High Yield And Low Co...
AstraZeneca's innovative culture earned it a place as one of the leading biotechs globally. Revenue growth from COVID vaccine sales and some key markets provide strong tailwinds for the company's share in the second half of 2021. Most of AstraZeneca's revenue comes from a handful ...
News, Short Squeeze, Breakout and More Instantly...
Orion Corp ADR Company Name:
ORINY Stock Symbol:
OTCMKTS Market:
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...